共 50 条
- [1] Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic reviewCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 125 : 1 - 11Mushtaq, AdeelaKapoor, VikasLatif, AzkaIftikhar, AhmadZahid, UmarMcBride, AliAbraham, IvoBin Riaz, IrbazAnwer, Faiz
- [2] Efficacy and Toxicity Profile of Ibrutinib Based Regimens for Refractory Multiple Myeloma: A Systematic ReviewBLOOD, 2018, 132Jamil, FaizaShafqat, MadeehaKhan, Ali YounasDurer, SerenDurer, CerenShah, ZunairahQureshi, AnumAbu Zar, MuhammadKamal, AhmadAhmad, Malik QistasSohail, Chaudhry SaadSelene, Insija IlyasMalik, Mustafa NadeemRafae, AbdulAnwer, Faiz
- [3] Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic ReviewBLOOD, 2019, 134Khan, MaimoonaWaheed, AsmaUl Jannat, RidaFarooqui, Arafat Ali AliFarooqi, Muhammad SaadKhan, Ali YounasShafqat, MadeehaAhmad, Muhaddis EjazYousaf, Muhammad AbdullahSyed, Tariq Iqtidar SadiqAbdullah, Syed MaazKotapati, SravanthiRiaz, IrbazAnwer, Faiz
- [4] Promising Clinical Efficacy and Toxicity Profile of Isatuximab Based Regimens for Treatment of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: A Systematic ReviewBLOOD, 2018, 132Shah, ZunairahShafqat, MadeehaJamil, FaizaMalik, Mustafa NadeemRafae, AbdulAslam, ShehrozQureshi, AnumSadiq, MaryamAbu Zar, MuhammadKamal, AhmadSelene, Insija IlyasSamuel, SharoonRiaz, RidaLakhani, MidhatAnwer, Faiz
- [5] A Systematic Review and Meta-Analysis: Efficacy and Toxicity Profile of Ixazomib for Treatment of Multiple MyelomaBLOOD, 2018, 132Shafqat, MadeehaJamil, FaizaShah, ZunairahKhan, Ali YounasDurer, SerenDurer, CerenAslam, ShehrozSelene, Insija IlyasQureshi, AnumAbu Zar, MuhammadHassan, Syed ShabeeJose, Jemin AbyFaridi, WardaAnwer, Faiz
- [6] Efficacy of Selinexor Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic ReviewBLOOD, 2020, 136Khalid, FarhanHashmi, Mydah SajidTayyeb, MuhammadJaan, AliAhmed, ZahoorDar, Abdul JabbarAamir, SobiaKhurshid, QasimKashyap, RichiKhan, IsrarRehman, Saif UrEhsan, HamidAnwer, Faiz
- [7] Efficacy and safety of carfilzomib for the treatment of multiple myeloma: An overview of systematic reviewsCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180Georgoulis, VasileiosHaidich, Anna-BettinaBougioukas, Konstantinos I.Hatzimichael, Eleftheria
- [8] Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-AnalysisBLOOD, 2018, 132Jamil, FaizaShafqat, MadeehaSamuel, SharoonShah, ZunairahDurer, CerenDurer, SerenSadiq, MaryamTariq, Muhammad JunaidJose, Jemin AbyFaridi, WardaBakr, Mohamed MokhtarZahid, UmarMcBride, AliSafdar, AhmadAnwer, Faiz
- [9] A systematic review of economic evaluations of treatment regimens in multiple myelomaEXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (04) : 799 - 809Asrar, Mir MahmoodLad, Deepesh P.Prinja, ShankarBansal, Dipika
- [10] Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myelomaBLOOD ADVANCES, 2020, 4 (21) : 5449 - 5459Facon, ThierryNiesvizky, RubenMateos, Maria-VictoriaSiegel, DavidRosenbaum, CaraBringhen, SaraWeisel, KatjaHo, P. JoyLudwig, HeinzKumar, ShajiWang, KennethObreja, MihaelaYang, ZhaoKlippel, ZandraMezzi, KhalidGoldrick, AmandaTekle, ChristinaDimopoulos, Meletios A.